MYC Induced Nuclear Antigen (MINA) Peptide
MINA
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN980090
Quick Overview for MYC Induced Nuclear Antigen (MINA) Peptide (ABIN980090)
Target
MINA
(MYC Induced Nuclear Antigen (MINA))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-MINA antibody (Catalog #: ARP39722_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MINA (MYC Induced Nuclear Antigen (MINA))
-
Background
-
MINA protein is directly involved in ribosome biogenesis, most likely during the assembly process of preribosomal particles. MINA is also involved in cell proliferation. MINA may have a role in esophageal squamous cell carcinoma, colon cancer and lung cancer
Alias Symbols: MDIG, NO52, MINA53
Protein Interaction Partner: MINA,MYC,MINA
Protein Size: 464 -
Molecular Weight
- 53 kDa
-
Gene ID
- 84864
-
NCBI Accession
- NM_032778, NP_116167
-
UniProt
- Q96KB0
Target
-
You are here:
